Beauty and cosmetics
Beauty and cosmeticsJapan and Korea market entry
K-beauty and J-beauty brands expanding across borders. Each market has distinct consumer preferences, review environments, and platform economics. We connect product trust, local search, reviews, and commerce into one acquisition path.
Entry requirements
- Local regulatory compliance confirmed (cosmetics claims, labeling, responsible party)
- Named owner for inventory, returns, and local-language customer support
- Contribution margin sufficient to absorb platform fees and acquisition costs
- Target marketplace or D2C channel decided and inventory in place
Key barriers
- Consumer preference differences between Japan and Korea (texture, ingredients, finish)
- Cosmetics claim and labeling regulations in each market
- Review accumulation and trust building on local beauty platforms
- Platform fees and acquisition costs relative to contribution margin
RIVACTA execution approach
- 01Local beauty review and comparison content connected to search demand
- 02Product page and search visibility optimization on priority platforms
- 03Trust content structure: reviews, ingredients, comparison, and FAQ
- 04Compliant paid demand and retargeting execution
KPI framework
- 01
Qualified product demand by channel
- 02
Product-page and checkout conversion rate
- 03
Acquisition cost against contribution margin after platform fees
- 04
Repeat purchase and subscription rate
Frequently Asked Questions
- Is K-beauty or J-beauty branding enough to win the market?
- Origin helps, but local proof, channel fit, and review/UGC strategy decide conversion; we build that structure rather than relying on origin alone.
- Which channels matter most for beauty?
- It depends on the target segment — we prioritize where discovery and trust actually form locally (search, social commerce, reviews) rather than a fixed list.
- Do you handle marketplace and D2C together?
- Yes — we align marketplace presence and owned D2C so they reinforce rather than cannibalize each other.
Regulatory notice
Under Japanese law, this industry is subject to strict licensing requirements and advertising-expression rules. Before contracting, RIVACTA reviews license and permit evidence, advertising expression, and any past administrative actions. Final responsibility for expression rests with the advertiser.
Under the Pharmaceuticals and Medical Devices Act and the Act against Unjustifiable Premiums and Misleading Representations, efficacy claims and exaggerated representations are reviewed individually.
Don't see your industry?
We confirm customer acquisition readiness and market direction first. A fit call reviews your current stage.